CATXStock Financials & Fundamentals
Company Info
Company Full Name
Perspective Therapeutics Inc.
Full name of the company.
Industry Name
Medical Devices
Industry name
Major Industry Name
Health Care Equipment & Supplies
Major industry name
Sector Name
Healthcare
Sector name
Market Info
Current Price
$3.20
Current price of the stock
Trading Volume
$974K
Trading volume of the stock
Market Capitalization
$372.1M
Market capitalization of the company
Market Cap Category
Small Cap
Category of market capitalization
Long-Term Growth Estimate
-19.62%
Long-term growth mean estimate
Analyst Rating Mean
4.64
Mean analyst rating
Potential Upside
294.39%
Potential price appreciation based on analyst price targets
EPS Surprise Percentage Difference
-
Percentage difference of EPS surprise
Dividends
Dividend Change (1 Year)
-
Dividend change over 1 year
Dividend Rate
$0.00
Shows the amount of dividend paid
Balance Sheet
Total Debt to Equity Ratio
0.00
Total debt to total equity ratio
Current Ratio
8.75
Current ratio
Company Profitability
Gross Profit Margin
-23415.65%
Gross profit margin
Operating Profit Margin
-361.21%
Operating profit margin
EBIT Margin
-361.21%
Earnings before interest and taxes (EBIT) margin
EBITDA Margin
-29629.83%
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
Pretax Profit Margin
-34459.21%
Pretax profit margin
Net Profit Margin
0.00%
Net profit margin
Return on Equity (ROE)
-39.57%
Measures profitability relative to shareholders' equity
Return on Tangible Equity
-8.52%
ROE excluding intangible assets
Return on Assets (ROA)
-22.28%
Measures profitability relative to total assets
Return on Invested Capital (ROIC)
-7.50%
Measures profitability relative to invested capital
Management Effectiveness
Asset Turnover (quarterly)
0.00
Asset turnover ratio
Inventory Turnover (quarterly)
-
Inventory turnover ratio
Receivables Turnover (quarterly)
1.31
Receivables turnover ratio
Days Sales Outstanding
68.68
Average number of days it takes to collect receivables
Valuation Measures
Price-to-Earnings (P/E) Ratio
-2.33
Measures valuation relative to earnings
Forward P/E Ratio
25.71
P/E based on future earnings estimates
Price-to-Sales (P/S) Ratio
909.86
Measures valuation relative to sales
Price-to-Book (P/B) Ratio
0.98
Measures valuation relative to book value
Price-to-Operating Cash Flow (P/OCF) Ratio
-1.18
Measures valuation relative to operating cash flow
Price-to-Free Cash Flow (P/FCF) Ratio
-1.03
Measures valuation relative to free cash flow
Cash Flow Statement
Net Acquisitions/Divestitures
0
Indicates company's M&A activity
CATXStock Financials & Fundamentals
Company Info
| Parameter | Value | Description |
|---|---|---|
| Company Full Name | Perspective Therapeutics Inc. | Full name of the company. |
| Industry Name | Medical Devices | Industry name |
| Major Industry Name | Health Care Equipment & Supplies | Major industry name |
| Sector Name | Healthcare | Sector name |
Market Info
| Parameter | Value | Description |
|---|---|---|
| Current Price | $3.20 | Current price of the stock |
| Trading Volume | $974K | Trading volume of the stock |
| Market Capitalization | $372.1M | Market capitalization of the company |
| Market Cap Category | Small Cap | Category of market capitalization |
| Long-Term Growth Estimate | -19.62% | Long-term growth mean estimate |
| Analyst Rating Mean | 4.64 | Mean analyst rating |
| Potential Upside | 294.39% | Potential price appreciation based on analyst price targets |
| EPS Surprise Percentage Difference | - | Percentage difference of EPS surprise |
Dividends
| Parameter | Value | Description |
|---|---|---|
| Dividend Change (1 Year) | - | Dividend change over 1 year |
| Dividend Rate | $0.00 | Shows the amount of dividend paid |
Balance Sheet
| Parameter | Value | Description |
|---|---|---|
| Total Debt to Equity Ratio | 0.00 | Total debt to total equity ratio |
| Current Ratio | 8.75 | Current ratio |
Company Profitability
| Parameter | Value | Description |
|---|---|---|
| Gross Profit Margin | -23415.65% | Gross profit margin |
| Operating Profit Margin | -361.21% | Operating profit margin |
| EBIT Margin | -361.21% | Earnings before interest and taxes (EBIT) margin |
| EBITDA Margin | -29629.83% | Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin |
| Pretax Profit Margin | -34459.21% | Pretax profit margin |
| Net Profit Margin | 0.00% | Net profit margin |
| Return on Equity (ROE) | -39.57% | Measures profitability relative to shareholders' equity |
| Return on Tangible Equity | -8.52% | ROE excluding intangible assets |
| Return on Assets (ROA) | -22.28% | Measures profitability relative to total assets |
| Return on Invested Capital (ROIC) | -7.50% | Measures profitability relative to invested capital |
Management Effectiveness
| Parameter | Value | Description |
|---|---|---|
| Asset Turnover (quarterly) | 0.00 | Asset turnover ratio |
| Inventory Turnover (quarterly) | - | Inventory turnover ratio |
| Receivables Turnover (quarterly) | 1.31 | Receivables turnover ratio |
| Days Sales Outstanding | 68.68 | Average number of days it takes to collect receivables |
Valuation Measures
| Parameter | Value | Description |
|---|---|---|
| Price-to-Earnings (P/E) Ratio | -2.33 | Measures valuation relative to earnings |
| Forward P/E Ratio | 25.71 | P/E based on future earnings estimates |
| Price-to-Sales (P/S) Ratio | 909.86 | Measures valuation relative to sales |
| Price-to-Book (P/B) Ratio | 0.98 | Measures valuation relative to book value |
| Price-to-Operating Cash Flow (P/OCF) Ratio | -1.18 | Measures valuation relative to operating cash flow |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.03 | Measures valuation relative to free cash flow |
Cash Flow Statement
| Parameter | Value | Description |
|---|---|---|
| Net Acquisitions/Divestitures | 0 | Indicates company's M&A activity |